1. Early detection through physical examination and screening The reporter learned from the regional tumor prevention and treatment research leading group office, which is in charge of the implementation of the “two cancers” project, that the project will first collect blood from the screeners to detect hepatitis B virus surface antigen and EBV antibodies, and include those who are positive in the high-risk group of liver cancer and nasopharyngeal cancer, and then further carry out liver cancer markers, serum alpha-fetoprotein test, liver ultrasound and nasopharyngeal microscopy to make a clear diagnosis. Serum fetoprotein test and ultrasound examination of liver and nasopharyngeal microscopy will be performed to clarify the diagnosis. The high-risk groups are followed up annually to achieve early detection of tumors and early treatment. From October 2013 to March this year, a total of more than 880,000 people were screened by blood collection in 22 project counties, of which more than 98,000 people were screened for high-risk liver cancer and more than 37,000 people for high-risk nasopharyngeal cancer. At present, 58 cases of nasopharyngeal cancer have been diagnosed, including 24 early cases, with an early diagnosis rate of 41.38%; 50 patients have been treated, with a treatment rate of 86.21%. There are 93 cases of liver cancer diagnosed, including 48 early cases, with an early diagnosis rate of 51.61%. 2. Early treatment is beneficial to recovery According to the introduction, early stage liver cancer and nasopharyngeal cancer have no obvious symptoms, and people can’t easily find the tumor if they don’t participate in physical examination and screening. And most people have many misconceptions about cancer. Some high-risk people found in screening feel no physical discomfort and are unwilling to participate in further diagnostic screening (including liver ultrasound and nasopharyngeal microscopy). At present, only about 1/4 of the high-risk group has participated in diagnostic screening, resulting in a low number of screened tumor patients. With the promotion of the “two cancers” project, the hospital has admitted a number of liver cancer patients found during the screening process, and more than half of them are early stage liver cancer patients. Patient Ou Moumou, a farmer from Cenxi County, Wuzhou City, was found to be positive for hepatitis B surface antigen and alpha-fetoprotein during the screening, and was highly suspected of having liver cancer. With the “Health Benefit Project Referral Certificate” issued by the township hospital, the patient was transferred to the Regional Cancer Hospital for hospitalization, which opened a “green channel” for him and completed various examinations in the shortest time. The hospital opened a “green channel” for him and completed various examinations within a short time. Most people think that they only go to hospital for examination when they feel unwell, but in fact, most cancers do not have any symptoms in the early stage, and liver cancer is no exception, once abdominal pain and other symptoms appear, the condition is likely to be in the middle and late stage, therefore, in order to detect liver cancer at an early stage, people with high risk of liver cancer (mainly hepatitis B patients) should go to hospital for medical examination once every six months and twice a year. In addition, many people think that liver cancer is an incurable disease and a “death sentence”, so they refuse to treat it. In fact, surgery for early stage liver cancer patients can achieve good therapeutic effect, and the 5-year survival rate can reach 60-70%, and some patients can be completely cured and survive for a long time. Compared with liver cancer, the treatment effect of nasopharyngeal cancer will be better. With the progress of radiotherapy, the 5-year survival rate of early-stage (stage I and II) nasopharyngeal cancer is close to 90%, and the 5-year survival rate of mid- and late-stage (stage III and IV) nasopharyngeal cancer is about 50%.